SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-09
👔
Entrada Therapeutics, Inc.
@TRDA_InsiderForm 4 Filing: MPM BioVentures 2018 LLC Sells $1.9M of $TRDA
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Entrada Therapeutics, Inc.
Ticker: $TRDA
Transaction Value
$1.9M
Price/Share: $7.33
transaction date
2026-09-08
Shares: 259,837
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, MPM BioVentures 2018 LLC, holds the title of 10% Owner at Entrada Therapeutics, Inc..
On 2026-09-08, the insider transacted 259,837 shares.The shares were transacted at a weighted average price of $7.33 per share, resulting in a total market-relevant value of $1.9M.
Executive Summary Summary
MPM BioVentures 2018 LLC (10% Owner) sold $1.9M of $TRDA
Post-Transaction Position: 3,913,952 shares
SEC Accession No: 0001231919-26-001156 (CIK: 1818702)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.